Background
==========

Ischemic stroke accounts for approximately 70--80% of all stroke, which is a leading cause of mortality and disability in China \[[@b1-medscimonit-23-4291],[@b2-medscimonit-23-4291]\]. In addition to common risk factors such as hypertension, diabetes, and smoking, recent studies have shown that genetic factors have important roles in the pathogenesis of ischemic stroke \[[@b3-medscimonit-23-4291],[@b4-medscimonit-23-4291]\].

It is common knowledge that the main cause of ischemic stroke is atherosclerosis. Recent studies showed that inflammatory reaction is an essential component in the appearance and development of atherosclerosis \[[@b5-medscimonit-23-4291]\]. The inflammatory gene CCL11 maps to chromosome 17q21.1, spans approximately 8 kb, and contains 3 exons \[[@b6-medscimonit-23-4291]\]. CCL11 is a chemokine exotoxin that promotes migration and activation of eosinophils, atheroma mast cells, and macrophages, participating in formation of atherosclerosis \[[@b7-medscimonit-23-4291]\]. Recent studies indicate that CCL11 may be associated with inflammatory-related diseases such as asthma \[[@b8-medscimonit-23-4291]\], atherosclerosis, and myocardial infarction \[[@b9-medscimonit-23-4291]\], and even stroke. However, few studies have explored the impact of tag SNPs in the CCL11 gene on subtypes of ischemic stroke. In the present study, we selected lacunar stroke and large-artery atherosclerotic (LAA) stroke patients and excluded cardiogenic embolism and non-atherosclerotic stroke patients. The aim of the study was to investigate the association of tag SNPs of the CCL11 gene with 2 subtypes of ischemic stroke in the Xinjiang Han population.

Material and Methods
====================

Ethics approval of the study protocol
-------------------------------------

The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China (NO. 20160512). Written informed consent was obtained from all participants.

Subjects
--------

Between Mar 2016 and Apr 2017, 406 lacunar stroke patients, 214 LAA stroke patients, and 425 controls were enrolled from the First Affiliated Hospital of Xinjiang Medical University and the 7th Division Hospital of Xinjiang. All participants were of Han ethnicity and were longtime residents of the Xinjiang region of China. Inclusion criteria of the case group were: (1) Stroke subtyping was performed according to the TOAST classification \[[@b10-medscimonit-23-4291]\]. Large-artery atherosclerosis (LAA) stroke was diagnosed when the patients had significant (\>50%) stenosis or occlusion of a major cerebral artery or branch cortical artery with infarct size \>1.5 cm on brain imaging \[[@b11-medscimonit-23-4291]\]. Lacunar stroke was defined as a clinical lacunar syndrome \[[@b12-medscimonit-23-4291]\], with an anatomically compatible lesion on MRI (≤1.5 cm in diameter). (2) Onset of stroke within 7 days. (3) Age 18--80 years old. Exclusion criteria were: (1) Coronary heart disease, atrial fibrillation, arteritis, or blood system disease. (2) Severe dysfunction of heart, lung, liver, or kidney. (3) Malignancy. (4) Cerebral hemorrhage, brain trauma, or intracranial tumor. (5) Immune system disease, Parkinson's disease, or hereditary diseases.

Controls consisted of persons who had participated in a health checkup without history of stroke and hospital patients without acute cerebrovascular disease, and cranial MRI or CT scan was normal. Exclusion criteria were the same as for the cases.

Clinical data collection
------------------------

The general information was recorded for all participants at admission: age, sex, smoking and drinking, and history of hypertension, diabetes mellitus, cardiac disease, and stroke. During the visit to the medical center, an emergency head CT was taken, and the next day an overnight fasting venous blood sample was taken to determine glucose and lipid levels. Locations and volume of infarcts were detected by brain MRI or CT.

Hypertension was defined as history of hypertension or using anti-hypertension drugs or if the mean of 3 measurements of systolic blood pressure (SBP) was \>140 mmHg or if diastolic blood pressure (DBP) was \>90 mmHg, respectively. Based on the criteria of the American Diabetes Association \[[@b13-medscimonit-23-4291]\], diabetes mellitus was defined as history of diabetes or taking an anti-hypoglycemic drug, or daytime random blood glucose ≥11.1 mmol/l or after fasting glucose ≥7.0 mmol/l or glucose in line 2 h ≥11.1mmol/l. Hyperlipidemia was defined as history of hyperlipidemia or TC \>5.72 mmol/L and (or) TG \>1.7 mmol/L.

Tag SNPS selection and genotyping
---------------------------------

Genomic DNA was extracted from peripheral blood of all participants based on the technique described elsewhere \[[@b14-medscimonit-23-4291]\]. We used Haploview 4.2 software to select the 5 tag SNPs in the CCL11 gene, including rs1129844, rs17809012, rs1860183, rs1860184, and rs4795898, based on minor allele frequency (MAF) \>0.1 and linkage disequilibrium patterns with r^2^\> 0.8 as a cut-off. In addition, we selected a tag SNP, rs4795895 (MAF\>0.05), which is a positive polymorphism reported in a previous study \[[@b15-medscimonit-23-4291]\]. These 6 tag SNPs captured the information of the 15 known CCL11 SNPs ([Figure 1B](#f1-medscimonit-23-4291){ref-type="fig"}). Genotyping was determined by improved multiple ligase detection reaction (iMLDR) \[[@b16-medscimonit-23-4291]\], with technical support from the Center for Human Genetic Research, Shanghai Genesky Biotech Company. The technicians performing genotyping were blinded to the cases and controls. About 10% of samples were randomly selected for further verification, and the results were 100% concordant.

Statistical analysis
--------------------

Categorical data are presented as numbers (percentage). Chi-square analyses were used for comparison. Univariate and multivariate logistic regression were used to obtain the crude and adjusted odds ratios (ORs) for assessment of CCL11 gene polymorphisms with risk of subtypes of ischemic stroke. Hardy-Weinberg equilibrium was tested by chi-square analysis. Bilateral *P*\<0.05 represented a significant difference. We used SPSS17.0 for analysis.

Results
=======

The study included 406 lacunar patients, 214 LAA stroke patients, and 425 controls. Baseline characteristics of cases and controls are presented in [Table 1](#t1-medscimonit-23-4291){ref-type="table"}. There were no significant differences between the lacunar or LAA group and control group in age, sex, hyperlipidemia, smoking, or drinking (*p*\>0.05). The prevalence of hypertension and diabetes was significantly higher in the lacunar and LAA stroke patients than in the control subjects (*p*\<0.05).

[Figure 1](#f1-medscimonit-23-4291){ref-type="fig"} shows a schematic of pairwise LD between SNPs in the CCL11 gene. All *D*′ values were 1 among the 6 tag SNPs, showing strong linkage disequilibrium. Pairwise LD of the 15 SNPs captured by the 6 tag SNPs are also indicated by r^2^ values.

Genotype and allele distributions of the 6 tag SNPs in patients with subtypes of ischemic stroke and control subjects are presented in [Table 2](#t2-medscimonit-23-4291){ref-type="table"}. All genotype distribution of cases and controls were consistent with the Hardy-Weinberg equilibrium (data not shown). For the rs4795895 polymorphism, the frequency of GG genotype and G allele was significantly higher in lacunar patients compared with control subjects (*p*\<0.05). For the rs17809012 polymorphism, the frequency of GA genotype and G allele was significantly higher in LAA patients compared with control subjects (*p*\<0.05). The results from logistic regression analyses are presented in [Table 3](#t3-medscimonit-23-4291){ref-type="table"}. Logistic regression analysis showed that the GG genotype of rs4795895 had a significant increase in the risk of lacunar stroke (adjusted OR=1.676, 95%CI=1.117--2.515), and the allele G was significantly associated with an increased risk of lacunar stroke (OR=1.617, 95%CI=1.136--2.302). The GA genotype of rs17809012 had a significant increase in the risk of LAA stroke (adjusted OR=1.337, 95%CI=1.127--1.585), and the allele G was significantly associated with an increased risk of LAA stroke (OR=1.287, 95%CI=1.009--1.641).

Hypertension stratification analyses between the 6 tag SNPs and risk of subtypes of ischemic stroke were carried out, and only meaningful polymorphism sites are presented in [Table 4](#t4-medscimonit-23-4291){ref-type="table"}. After stratification by hypertension and adjustment for age, sex, diabetes mellitus, hyperlipidemia, smoking, and drinking, the GA genotype of rs17809012 was significantly associated with LAA stroke in the hypertensive group (adjusted OR=1.274, 95%CI=1.015--1.601). In the non-hypertensive group, the GA genotype of rs17809012 was significantly associated with LAA stroke (adjusted OR=1.361, 95%CI=1.041--1.780). The GG genotype of rs4795895 (adjusted OR=1.147, 95%CI=1.115--4.134) and the TT genotype of rs1860184 were significantly associated with lacunar stroke (adjusted OR=2.440, 95%CI=1.550--3.840).

Discussion
==========

CCL11 (Eotaxin1) is a member of the CC chemokine family and operates through the receptor for eotaxin (CCR3) \[[@b17-medscimonit-23-4291]\]. CCR3 receptor acts on Th2 lymphocytes, basophils, mast cells, and eosinophils \[[@b18-medscimonit-23-4291]\], which participate in inflammation. CCL11 is an eosinophil chemotactic factor, and its roles are to direct eosinophils towards the sites of inflammation, promote degranulation, and release eosinophil cationic proteins. Eotaxin plays an important role in the formation of atherosclerosis, and evidence suggests it is overexpressed in endothelium and vascular smooth muscle cells in human atheroma \[[@b19-medscimonit-23-4291]\]. The mechanism may be that eotaxin promotes endothelial cell migration *in vitro,* as well as angiogenesis and endothelial cell sprouting from the artery \[[@b20-medscimonit-23-4291]--[@b22-medscimonit-23-4291]\].

Recent studies showed that lacunar stroke is a highly heritable and complex disease \[[@b12-medscimonit-23-4291]\]. In this study, we investigated the relationship between 6 tag SNPs of CCL11 with the risk of lacunar stroke in 406 cases and 425 controls. The results showed that rs4795895 was significantly associated with lacunar stroke, but was not found in LAA stroke. After adjusting for age, sex, hypertension, diabetes mellitus, hyperlipidemia, smoking, and drinking, multiple logistic regression analysis showed that the odds of lacunar stroke were 1.676 times greater in patients with GG genotype than in those without GG genotype, indicating that the GG genotype of rs4795895 may be a potential risk for lacunar stroke. Zhao et al. \[[@b15-medscimonit-23-4291]\] found that CCL11 rs4795895 was significantly associated with ischemic stroke in a Chinese Han population. However, in contrast to our choice of subtypes of ischemic stroke, they selected all types of stroke patients to observe. Sitara Roy et al. \[[@b23-medscimonit-23-4291]\] found that CCL11 rs4795895 was significantly associated with lacunar stroke or LAA stroke in a southern Indian population. However, we found no correlation between rs4795895 and LAA stroke. These studies were partly consistent with our study results. The differences may be due to characteristics of participants, as well as regional and ethnic factors.

A previous study reported that stroke patients with or without hypertension may have different pathogenesis \[[@b24-medscimonit-23-4291]\]. To explore the influence of CCL11 genes on subtypes of ischemic stroke in the hypertension and non-hypertension groups, hypertension stratification analyses were performed. After stratification by hypertension, SNP rs4795895 was significantly associated with lacunar stroke in the non-hypertensive groups. We found a novel polymorphism (rs1860184) associated with lacunar stroke in non-hypertensive populations. The TT genotype of rs1860184 was significantly associated with lacunar stroke in the non-hypertensive groups, indicating that the TT genotype may be a potential risk for lacunar stroke in people without hypertension. In clinical practice, there are some stroke patients without hypertension, diabetes, and other risk factors, but with higher levels of arteriosclerosis; this may be due to genetics. In future studies, patients with fewer risk factors should be selected, which may better identify the pathogenic gene *loci* for ischemic stroke. Although microatheroma constitutes the main etiology, lacunar infarcts may be caused in less than 5% of cases, by various etiologies, mainly hematological diseases and infectious or inflammatory arteritis \[[@b25-medscimonit-23-4291]\]. An interesting area of future research could be to investigate the association of tag SNPs of the CCL11 gene in this unusual etiological lacunar infarct subgroup of patients.

In the present study, we found a novel polymorphism (rs17809012) associated with LAA stroke in the Chinese Han population. The odds of LAA stroke were 1.337 times greater in patients with GA genotype than in those without the GA genotype, indicating that the GA genotype of rs17809012 may be a potential risk factor for LAA stroke. Hypertension stratification analyses showed that rs17809012 remained significant in hypertensive and non-hypertensive groups.

There are limitations to our study. Firstly, the procedures of selecting and grouping patients could not exclude possible selection bias. Secondly, the clinical data were gathered by self-reported questionnaires, which could lead to information bias. Thirdly, because the percentage of diabetes in the control group was too low, diabetes stratification analyses were not carried out. Prospective studies with larger sample sizes are needed.

Conclusions
===========

This study demonstrates that rs4795895 of the CCL11 gene might be associated with lacunar stroke, particularly in the non-hypertensive group. rs1860184 was associated with a higher risk of lacunar stroke in the non-hypertensive group. rs17809012 was associated with LAA stroke in the Chinese Han population.
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![Schematic of pairwise LD between the six tagSNPs with in CCL11 gene. All *D*′ values are 1 among the sixtag SNPs (**A**). Details of fifteen respective SNPs captured by the six tagSNPs are indicated. The r^2^ values are plotted as a graph to show the linkage disequlibrium among the fifteen SNPs captured by these six tagSNPs (**B**).](medscimonit-23-4291-g001){#f1-medscimonit-23-4291}

###### 

Baseline characteristics of lacunar, LAA stroke patients and control subjects.

  Characteristics                                                              Lacunar (n=406)                                                  LAA (n=214)                                                      Control (n=425)
  ---------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------- -----------------
  Age (years)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}                                                                                                                                                 
   \<60                                                                        178 (43.8)                                                       93 (43.5)                                                        192 (45.2)
   60--70                                                                      165 (40.6)                                                       89 (41.6)                                                        173 (40.7)
   \>70                                                                        63 (15.5)                                                        32 (14.9)                                                        60 (14.1)
  Male, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}               245 (60.3)                                                       136 (63.6)                                                       238 (56.0)
  Hypertension, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}       258 (63.5)[\*](#tfn2-medscimonit-23-4291){ref-type="table-fn"}   134 (62.6)[\*](#tfn2-medscimonit-23-4291){ref-type="table-fn"}   196 (46.1)
  Diabetesmellitus, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}   131 (32.3)[\*](#tfn2-medscimonit-23-4291){ref-type="table-fn"}   60 (28.0)[\*](#tfn2-medscimonit-23-4291){ref-type="table-fn"}    52 (12.2)
  Hyperlipidemia, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}     122 (30.0)                                                       68 (31.8)                                                        119 (28.0)
  Smoking, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}            129 (31.8)                                                       63 (29.4)                                                        114 (26.8)
  Drinking, n (%)[1](#tfn1-medscimonit-23-4291){ref-type="table-fn"}           52 (12.8)                                                        24 (11.2)                                                        45 (10.6)

Chi-square between the group of LI, LAA and controls;

*P*\<0.05.

###### 

Genotype and allele distributions of the six SNPS in patients with subtypes of ischemic stroke and control subjects.

  Genotypes    Lacunar       Control       *P* value   LAA           *P* value
  ------------ ------------- ------------- ----------- ------------- -----------
  rs1129844                                                          
   GG          301 (74.1%)   325 (76.5%)   0.585       158 (73.8%)   0.547
   GA          100 (24.6%)   93 (21.9%)                50 (23.4%)    
   AA          5 (1.2%)      7 (1.6%)                  6 (2.8%)      
   Allele G    702 (86.5%)   743 (87.4%)   0.562       366 (85.5%)   0.345
   Allele A    110 (13.5%)   107 (12.6%)               62 (14.5%)    
  rs17809012                                                         
   GG          36 (8.9%)     38 (8.9%)     0.856       17 (7.9%)     0.006^\*^
   GA          178 (43.8%)   194 (45.6%)               126 (58.9%)   
   AA          192 (47.3%)   193 (45.4%)               71 (33.2%)    
   Allele G    250 (30.8%)   270 (31.8%)   0.668       160 (37.4%)   0.045^\*^
   Allele A    562 (69.2%)   580 (68.2%)               268 (62.6%)   
  rs1860183                                                          
   CC          248 (61.1%)   255 (60.0%)   0.799       115 (53.7%)   0.152
   CT          140 (34.5%)   154 (36.2%)               85 (39.7%)    
   TT          18 (4.4%)     16 (3.8%)                 14 (6.6%)     
   Allele C    636 (78.3%)   664 (78.1%)   0.918       315 (73.6%)   0.072
   Allele T    176 (21.7%)   186 (21.9%)               113 (26.4%)   
  rs1860184                                                          
   TT          157 (38.7%)   149 (35.1%)   0.432       66 (30.8%)    0.391
   TA          196 (48.3%)   210 (49.4%)               118 (55.2%)   
   AA          53 (13.0%)    66 (15.5%)                30 (14.0%)    
   Allele T    510 (62.8%)   508 (59.8%)   0.203       250 (58.4%)   0.642
   Allele A    302 (37.2%)   342 (40.2%)               178 (41.6%)   
  rs4795895                                                          
   GG          357 (87.9%)   345 (81.2%)   0.024^\*^   181 (84.6%)   0.426
   GA          44 (10.8%)    74 (17.4%)                29 (13.5%)    
   AA          5 (1.2%)      6 (1.4%)                  4 (1.9%)      
   Allele G    758 (93.3%)   764 (89.9%)   0.011^\*^   391 (91.4%)   0.399
   Allele A    54 (6.7%)     86 (10.1%)                37 (8.6%)     
  rs4795898                                                          
   CC          18 (4.4%)     7 (1.7%)      0.059       6 (2.8%)      0.317
   CT          103 (25.4%)   106 (24.9%)               44 (20.6%)    
   TT          285 (70.2%)   312 (79.4%)               164 (76.6%)   
   Allele C    139 (17.1%)   120 (14.1%)   0.092       56 (13.1%)    0.613
   Allele T    673 (82.9%)   730 (85.9%)               372 (86.9%)   

###### 

Association of rs17809012, rs4795895 polymorphisms with risk of subtypes of ischemic stroke.

                Crude OR (95%CI)       Crude *P*   Adjust OR (95%CI)[a](#tfn3-medscimonit-23-4291){ref-type="table-fn"}   Adjust *P*[a](#tfn3-medscimonit-23-4291){ref-type="table-fn"}
  ------------- ---------------------- ----------- ---------------------------------------------------------------------- ---------------------------------------------------------------
  **Lacunar**                                                                                                             
  rs4795895                                                                                                               
   GG           1.685 (1.146--2.476)   0.008^\*^   1.676 (1.117--2.515)                                                   0.013^\*^
   GA           0.760 (0.622--0.929)   0.007^\*^   0.775 (0.627--0.957)                                                   0.018^\*^
   AA           0.956 (0.642--1.423)   0.823       0.867 (0.575--1.308)                                                   0.497
   G allele     1.617 (1.136--2.302)   0.008^\*^                                                                          
   A allele     0.626 (0.440--0.893)   0.010^\*^                                                                          
  **LAA**                                                                                                                 
  rs17809012                                                                                                              
   GG           0.881 (0.485--1.601)   0.678       0.898 (0.484--1.667)                                                   0.733
   GA           1.348 (1.144--1.590)   0.000^\*^   1.337 (1.127--1.585)                                                   0.001^\*^
   AA           0.848 (0.757--0.950)   0.005^\*^   0.853 (0.758--0.960)                                                   0.008^\*^
   G allele     1.287 (1.009--1.641)   0.042^\*^                                                                          
   A allele     0.793 (0.622--1.012)   0.062                                                                              

Adjust for age, sex, hypertension, diabetes, hyperlipidemia, smoking, drinking.

###### 

Hypertension stratification analyses between SNP and risk of subtypes of ischemic stroke.

  Variables              N (cases/controls)   Percentage (cases/controls)   Adjusted OR (95%CI)[a](#tfn4-medscimonit-23-4291){ref-type="table-fn"}   *p* Value
  ---------------------- -------------------- ----------------------------- ------------------------------------------------------------------------ -----------
  **Hypertension**                                                                                                                                   
  rs4795895 (Lacunar)    258/196                                                                                                                     
   GG                    226/170              87.6/86.7                     1.161 (0.660--2.044)                                                     0.604
   GA                    29/22                11.2/11.2                     0.959 (0.711--1.293)                                                     0.782
   AA                    3/4                  1.2/2.1                       0.835 (0.500--1.397)                                                     0.493
  rs1860184 (Lacunar)                                                                                                                                
   TT                    82/72                31.8/36.7                     0.770 (0.516--1.149)                                                     0.201
   TA                    140/95               54.3/48.5                     1.134 (0.937--1.372)                                                     0.196
   AA                    36/29                13.9/14.8                     1.016 (0.848--1.216)                                                     0.867
  rs17809012 (LAA)       134/196                                                                                                                     
   GG                    12/20                8.9/10.2                      0.978 (0.451--2.121)                                                     0.954
   GA                    75/87                56.0/44.4                     1.274 (1.015--1.601)                                                     0.037^\*^
   AA                    47/89                35.1/45.4                     0.878 (0.752--1.026)                                                     0.101
  **Non-hypertension**                                                                                                                               
  rs4795895 (Lacunar)    148/229                                                                                                                     
   GG                    132/186              89.2/81.2                     1.147 (1.115--4.134)                                                     0.022^\*^
   GA                    14/41                9.5/18.0                      0.689 (0.491--0.968)                                                     0.032^\*^
   AA                    2/2                  1.3/0.8                       0.809 (0.424--1.544)                                                     0.520
  rs1860184 (Lacunar)                                                                                                                                
   TT                    75/77                50.7/33.6                     2.440 (1.550--3.840)                                                     0.000^\*^
   TA                    56/115               37.8/50.2                     0.739 (0.591--0.924)                                                     0.008^\*^
   AA                    17/37                11.5/16.2                     0.857 (0.686--1.069)                                                     0.170
  rs17809012 (LAA)       80/229                                                                                                                      
   GG                    5/18                 6.3/7.9                       0.887 (0.310--2.537)                                                     0.822
   GA                    51/107               63.7/46.7                     1.361 (1.041--1.780)                                                     0.024^\*^
   AA                    24/104               30.0/45.4                     0.790 (0.655--0.954)                                                     0.014^\*^

Adjust for age, sex, diabetes, hyperlipidemia, smoking, drinking.
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